top
Search terms
Results 1 - 10 of 13 - ordered by :
Pages: 1 2
Ejhf

According to the authors, spectral MTWA testing was not widely applicable and failed to predict mortality in the studied group: the mortality rates of positive, negative, and indeterminate MTWA ...

European Journal of Heart Failure, Danilowicz‐Szymanowicz, Ludmila, Molon, Giulio, Raczak, Grzegorz

Date : 01/01/2014 Item size : 57260 bytes
Epeuropace

Intuitively, programmed electrical stimulation (PES) should contribute to risk stratification for ventricular arrhythmias: it may demonstrate the presence of a substrate capable of sustained ...

EP Europace, Editorial, Chris Plummer

Date : 01/03/2009 Item size : 143438 bytes
Epeuropace

Non-invasive risk stratification for sudden cardiac death by heart rate turbulence and microvolt T-wave alternans in patients after myocardial infarction Abstract Aims To evaluate the predictive ...

Europace, Electrocardiology and risk stratification, Vitaly Sulimov, Elena Okisheva, Dmitry Tsaregorodtsev

Date : 01/12/2012 Item size : 215963 bytes
Epeuropace

Twelve studies (5009 patients) recruiting patients with coronary artery disease or non-ischaemic cardiomyopathy met our inclusion criteria. Impairment of left ventricular (LV) function and QRS ...

Europace, Electrocardiology and risk stratification, James A. Rosengarten, Paul A. Scott, John M. Morgan

Date : 01/06/2015
Epeuropace

Abstract Aims The EUTrigTreat clinical study has been designed as a prospective multicentre observational study and aims to (i) risk stratify patients with an implantable cardioverter defibrillator ...

Europace, CLINICAL RESEARCH, Joachim Seegers, Marc A. Vos, Panagiota Flevari, Rik Willems, Christian Sohns, Dirk Vollmann, Lars Lüthje, Dimitrios T. Kremastinos, Vincent Floré, Mathias Meine, ...

Date : 01/03/2012
Heart

Using a random-effects model, there was a trend towards reduced overall mortality in patients undergoing early AVR compared with a symptom-driven AVR approach (OR 0.54, 95% CI 0.26 to 1.12, ...

Heart, Valvular heart disease, Wei Yao Lim, Anantharaman Ramasamy, Guy Lloyd, Sanjeev Bhattacharyya

Date : 15/02/2017
Ehjournal

Primary prevention of SCD in post-MI and heart failure The revision of the section of primary prevention of SCD in post-MI and heart failure has been considered appropriate based on the release of ...

European Heart Journal, Priori, Silvia G, Aliot, Etienne, Blomstrom-Lundqvist, Carina, Bossaert, Leo, Breithardt, Gunter, Brugada, Pedro, Camm, John A, Cappato, Riccardo, Cobbe, Stuart M, Di Mario, ...

Date : 01/01/2003 Item size : 119985 bytes
Ehjournal

Primary prevention of SCD in post-MI and heart failure The revision of the section of primary prevention of SCD in post-MI and heart failure has been considered appropriate based on the release of ...

European Heart Journal, Priori, Silvia G, Aliot, Etienne, Blomstrom-Lundqvist, Carina, Bossaert, Leo, Breithardt, Gunter, Brugada, Pedro, Camm, John A, Cappato, Riccardo, Cobbe, Stuart M, Di Mario, ...

Date : 01/01/2003
Ehjournal

1 Primary prevention of SCD in post-MI and heart failure The revision of the section of primary prevention of SCD in post-MI and heart failure has been considered appropriate based on the release of ...

European Heart Journal, Priori, Silvia G, Aliot, Etienne, Blomstrom-Lundqvist, Carina, Bossaert, Leo, Breithardt, Gunter, Brugada, Pedro, Camm, John A, Cappato, Riccardo, Cobbe, Stuart M, Di Mario, ...

Date : 01/01/2003
Ehjournal

At a competing risk multivariable analysis adjusted for baseline variables, no significant difference in primary endpoint was found between patients with C-reactive protein 3 vs. >3 mg/L [heart rate ...

European Heart Journal, Biasucci, Luigi M., Bellocci, Fulvio, Landolina, Maurizio, Rordorf, Roberto, Vado, Antonello, Menardi, Endrj, Giubilato, Giovanna, Orazi, Serafino, Sassara, Massimo, Castro, ...

Date : 01/06/2012